UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

EditR: A Method to Quantify Base Editing from Sanger Sequencing

CRISPR journal, 2018-06, Vol.1 (3), p.239-250

2018

Volltextzugriff (PDF)

Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editors

Nature communications, 2019-11, Vol.10 (1), p.5222-10, Article 5222

2019

Volltextzugriff (PDF)

A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer Immunotherapy

Molecular therapy, 2020-01, Vol.28 (1), p.52-63

2020

Volltextzugriff (PDF)

Base Editor Correction of COL7A1 in Recessive Dystrophic Epidermolysis Bullosa Patient-Derived Fibroblasts and iPSCs

Journal of investigative dermatology, 2020-02, Vol.140 (2), p.338-347.e5

2020

Volltextzugriff (PDF)

Engineering of Primary Human B cells with CRISPR/Cas9 Targeted Nuclease

Scientific reports, 2018-08, Vol.8 (1), p.12144-9, Article 12144

2018

Volltextzugriff (PDF)

Engineering T cells to enhance 3D migration through structurally and mechanically complex tumor microenvironments

Nature communications, 2021-05, Vol.12 (1), p.2815-2815, Article 2815

2021

Volltextzugriff (PDF)

Highly multiplexed genome engineering using CRISPR/Cas9 gRNA arrays

PloS one, 2018-09, Vol.13 (9), p.e0198714-e0198714

2018

Volltextzugriff (PDF)

CRISPR-Cas9 cytidine and adenosine base editing of splice-sites mediates highly-efficient disruption of proteins in primary and immortalized cells

Nature communications, 2021-04, Vol.12 (1), p.2437-2437, Article 2437

2021

Volltextzugriff (PDF)

A BAFF ligand-based CAR-T cell targeting three receptors and multiple B cell cancers

Nature communications, 2022-01, Vol.13 (1), p.217-217, Article 217

2022

Volltextzugriff (PDF)

Evaluation of TCR Gene Editing Achieved by TALENs, CRISPR/Cas9, and megaTAL Nucleases

Molecular therapy, 2016-03, Vol.24 (3), p.570-581

2016

Volltextzugriff (PDF)

Rapid DNA replication origin licensing protects stem cell pluripotency

eLife, 2017-11, Vol.6

2017

Volltextzugriff (PDF)

Germline T cell receptor exchange results in physiological T cell development and function

Nature communications, 2023-02, Vol.14 (1), p.528-19, Article 528

2023

Volltextzugriff (PDF)

CRISPR/Cas9-Mediated Correction of the FANCD1 Gene in Primary Patient Cells

International journal of molecular sciences, 2017-06, Vol.18 (6), p.1269

2017

Volltextzugriff (PDF)

Rapid generation of Col7a1 -/- mouse model of recessive dystrophic epidermolysis bullosa and partial rescue via immunosuppressive dermal mesenchymal stem cells

Laboratory investigation, 2017-10, Vol.97 (10), p.1218-1224

2017

Volltextzugriff (PDF)

A Pan-RNase Inhibitor Enabling CRISPR-mRNA Platforms for Engineering of Primary Human Monocytes

International journal of molecular sciences, 2022-09, Vol.23 (17), p.9749

2022

Volltextzugriff (PDF)

MultiEditR: The first tool for the detection and quantification of RNA editing from Sanger sequencing demonstrates comparable fidelity to RNA-seq

Molecular therapy. Nucleic acids, 2021-09, Vol.25, p.515-523

2021

Volltextzugriff (PDF)

Correction of Fanconi Anemia Mutations Using Digital Genome Engineering

International journal of molecular sciences, 2022-07, Vol.23 (15), p.8416

2022

Volltextzugriff (PDF)

CRISPR/Cas9-Based Cellular Engineering for Targeted Gene Overexpression

International journal of molecular sciences, 2018-03, Vol.19 (4), p.946

2018

Volltextzugriff (PDF)

Development and testing of a versatile genome editing application reporter (V-GEAR) system

Molecular therapy. Methods & clinical development, 2024-06, Vol.32 (2), p.101253-101253, Article 101253

2024

Volltextzugriff (PDF)

CRISPR/Cas9-based genetic correction for recessive dystrophic epidermolysis bullosa

npj Regenerative medicine, 2016-12, Vol.1 (1), p.16014, Article 16014

2016

Volltextzugriff (PDF)

Author Correction: Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editors

Nature communications, 2019-12, Vol.10 (1), p.5659-1, Article 5659

2019

Volltextzugriff (PDF)

Myosin Heavy Chain Converter Domain Mutations Drive Early-Stage Changes in Extracellular Matrix Dynamics in Hypertrophic Cardiomyopathy

Frontiers in cell and developmental biology, 2022-06, Vol.10, p.894635-894635

2022

Volltextzugriff (PDF)

Advancing gene targeting for primary immune deficiencies: Adenine base editing of the human IL2RG locus for correction of SCID-X1

Molecular therapy, 2024-06, Vol.32 (6), p.1606-1608

2024

Volltextzugriff (PDF)

Comparative international incidence of Ewing sarcoma 1988 to 2012

International journal of cancer, 2021-09, Vol.149 (5), p.1054-1066

2021

Volltextzugriff (PDF)

Dermatopontin in Bone Marrow Extracellular Matrix Regulates Adherence but Is Dispensable for Murine Hematopoietic Cell Maintenance

Stem cell reports, 2017-09, Vol.9 (3), p.770-778

2017

Volltextzugriff (PDF)

1 – 25 von 65

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(64)
Mit Volltextzugriff
(57)

Publikationsform

Artikel
(65)

Sprache

Englisch
(65)

Erscheinungsjahr

n.n

Thema

Science & Technology
(47)
Life Sciences & Biomedicine
(37)
Humans
(27)
Animals
(16)
Medicine, Research & Experimental
(15)
Research & Experimental Medicine
(15)
Crispr
(14)
Genomes
(13)
Mice
(13)
Genetics & Heredity
(11)
Cells, Cultured
(10)
Biotechnology & Applied Microbiology
(9)
Genome Editing
(9)
Lymphocytes
(9)
Cell Differentiation
(8)
Crispr-Cas Systems
(8)
Multidisciplinary Sciences
(8)
Science & Technology - Other Topics
(8)
Hematology
(7)
Cancer
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

EditR: A Method to Quantify Base Editing from Sanger Sequencing

Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editors

A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer Immunotherapy

Base Editor Correction of COL7A1 in Recessive Dystrophic Epidermolysis Bullosa Patient-Derived Fibroblasts and iPSCs

Engineering of Primary Human B cells with CRISPR/Cas9 Targeted Nuclease

Engineering T cells to enhance 3D migration through structurally and mechanically complex tumor microenvironments

Highly multiplexed genome engineering using CRISPR/Cas9 gRNA arrays

CRISPR-Cas9 cytidine and adenosine base editing of splice-sites mediates highly-efficient disruption of proteins in primary and immortalized cells

A BAFF ligand-based CAR-T cell targeting three receptors and multiple B cell cancers

Evaluation of TCR Gene Editing Achieved by TALENs, CRISPR/Cas9, and megaTAL Nucleases

Rapid DNA replication origin licensing protects stem cell pluripotency

Germline T cell receptor exchange results in physiological T cell development and function

CRISPR/Cas9-Mediated Correction of the FANCD1 Gene in Primary Patient Cells

Rapid generation of Col7a1 -/- mouse model of recessive dystrophic epidermolysis bullosa and partial rescue via immunosuppressive dermal mesenchymal stem cells

A Pan-RNase Inhibitor Enabling CRISPR-mRNA Platforms for Engineering of Primary Human Monocytes

MultiEditR: The first tool for the detection and quantification of RNA editing from Sanger sequencing demonstrates comparable fidelity to RNA-seq

Correction of Fanconi Anemia Mutations Using Digital Genome Engineering

CRISPR/Cas9-Based Cellular Engineering for Targeted Gene Overexpression

Development and testing of a versatile genome editing application reporter (V-GEAR) system

CRISPR/Cas9-based genetic correction for recessive dystrophic epidermolysis bullosa

Author Correction: Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editors

Myosin Heavy Chain Converter Domain Mutations Drive Early-Stage Changes in Extracellular Matrix Dynamics in Hypertrophic Cardiomyopathy

Advancing gene targeting for primary immune deficiencies: Adenine base editing of the human IL2RG locus for correction of SCID-X1

Comparative international incidence of Ewing sarcoma 1988 to 2012

Dermatopontin in Bone Marrow Extracellular Matrix Regulates Adherence but Is Dispensable for Murine Hematopoietic Cell Maintenance

Suchergebnisse filtern